Across the recent three months, 8 analysts have shared their insights on Gilead Sciences (NASDAQ:GILD), expressing a variety of opinions spanning from bullish to bearish. In the table below, you’ll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. In the assessment of 12-month price targets, analysts unveil insights for Gilead Sciences, presenting an average target of $77.25, a high estimate of $93.00, and a low estimate of $70.00. Observing a 3.19% increase, the current average has risen from the previous…